PROFESSIONAL EDITION

The largest community of pharma leaders

Cedilla Therapeutics Appoints Delphine Collin, Ph.D., as Vice President, Biomolecular Sciences

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cedilla Therapeutics today announced the appointment of Delphine Collin, Ph.D., as vice president, biomolecular sciences. http://www.businesswire.com/news/home/20190514005180/en/Cedilla-Therapeutics-Appoints-Delphine-Collin-Ph.D.-Vice/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

Recent Articles